Studying the Effects of TCDD on HepG2 Cells Using Metabolomics
Author Information
Author(s): Ruiz-Aracama Ainhoa, Peijnenburg Ad, Kleinjans Jos, Jennen Danyel, van Delft Joost, Hellfrisch Caroline, Lommen Arjen
Primary Institution: RIKILT-Institute of Food Safety, Wageningen University and Research Centre
Hypothesis
The study aims to develop an untargeted metabolomics methodology for in vitro systems to analyze the effects of TCDD on HepG2 cells.
Conclusion
The study demonstrates that untargeted metabolomics is a valid approach to studying the effects of TCDD on HepG2 cells, with reproducible results that align with previous research.
Supporting Evidence
- Metabolomics can provide insights into the metabolic responses of cells to toxicants.
- The study found significant changes in metabolite levels after TCDD exposure.
- Normalization methods were crucial for detecting metabolic changes.
- Results were consistent with previous studies on TCDD's effects.
- Multiple analytical techniques were used to ensure comprehensive data collection.
Takeaway
Researchers looked at how a harmful chemical affects liver cells in a lab, finding that it changes the cells' metabolism in ways that match what other studies have shown.
Methodology
The study used NMR, LC-MS, and GC-MS to analyze intracellular metabolites from HepG2 cells exposed to TCDD for 48 hours.
Potential Biases
Potential biases may arise from the normalization methods and the variability in cell culture conditions.
Limitations
The study's findings may vary due to differences in cell passage numbers and the need for sufficient biological replicates.
Participant Demographics
Human liver cell line HepG2 was used, with experiments conducted across different cell passage numbers.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website